Another great update from EMV
Super excited to see how the clinical trials go, this next phase is a company maker and all signs are looking positive! Not much longer to wait for potential commercial sales in the grand scheme of things - we’ve been ticking boxes at an incredible pace with management delivering on their timelines and communicating updates clearly and concisely. It’s truly remarkable that the company has only raised capital once since inception, a testament to the quality of our ship and the professionalism and commitment of our navigators.
- Forums
- ASX - By Stock
- EMV
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-10
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.94 |
Change
-0.065(3.25%) |
Mkt cap ! $165.4M |
Open | High | Low | Value | Volume |
$2.00 | $2.00 | $1.94 | $102.8K | 52.37K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 150 | $1.91 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.94 | 2843 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 150 | 1.910 |
1 | 5639 | 1.900 |
1 | 1580 | 1.890 |
1 | 2000 | 1.850 |
1 | 1094 | 1.825 |
Price($) | Vol. | No. |
---|---|---|
1.940 | 2843 | 1 |
1.970 | 7867 | 1 |
2.020 | 25278 | 2 |
2.060 | 1769 | 1 |
2.100 | 2308 | 1 |
Last trade - 15.29pm 13/11/2024 (20 minute delay) ? |
Featured News
EMV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online